Skip to main content
. 2017 Nov 23;1:38. doi: 10.1038/s41698-017-0040-z

Table 2.

Geometric means of plasma fatty acids and their desaturase indices among patients with colon or rectal cancer and their matched control subjects, the Singapore Chinese Health Study

Colon Rectal
Cases (n = 211) Controls (N = 211) P-valuea Cases (n = 139) Controls (N = 139) P- valuea
Monounsaturated fatty acid (MUFA) synthesis pathway
Saturated fatty acids
 Palmitic acid (16:0), µmol/dL 265.82 282.64 0.078 277.74 269.14 0.415
 Stearic acid (18:0), µmol/dL 92.62 97.32 0.097 96.74 93.88 0.369
MUFAs
 Palmitoleic acid (16:1), µmol/dL 18.54 20.82 0.061 20.88 20.40 0.765
 Oleic acid (18:1), µmol/dL 282.76 311.10 0.020 310.14 293.14 0.236
Stearoyl-coenzyme A desaturase (SCD)-1 indices
 Palmitoleic:Palmitic acid ratio 0.06 0.08 0.221 0.08 0.08 0.881
 Oleic:Stearic acid ratio 3.48 3.64 0.055 3.64 3.54 0.362
n-3 Polyunsaturated fatty acids (PUFAs)
 α-Linolenic acid (18:3), µmol/dL 2.50 2.88 0.009 2.78 2.58 0.260
 Eicosapentanoic acid (20:5), µmol/dL 3.52 3.48 0.862 3.48 3.52 0.873
 Docosahexaenoic acid (22:6), µmol/dL 24.04 23.68 0.777 25.02 25.82 0.604
n-6 PUFA synthesis pathway
n-6 PUFAs
 Linoleic acid (18:2) (LA), µmol/dL 569.04 600.26 0.044 591.76 570.82 0.286
 γ-Linolenic acid (18:3) (GLA), µmol/dL 1.54 1.82 0.030 1.58 1.50 0.590
 Dihomo-γ-linolenic acid (20:3) (DGLA), µmol/dL 7.38 8.06 0.064 7.88 7.20 0.154
 Arachidonic acid (20:4) (AA), µmol/dL 73.16 69.72 0.207 75.80 71.38 0.210
n-6 PUFA desaturase indices (DI)
 GLA:LA ratio (for Δ6 DI) (×1000) 2.7 3.2 0.137 2.6 2.6 0.869
 AA:DGLA ratio (for Δ5 DI) 9.84 8.58 0.002 9.56 9.86 0.525
 AA:LA ratio (for total n-6 PUFA DI) (×1000) 129 116 0.005 128 125 0.615

a P-value for difference between case and control groups were derived from one-way ANOVA for log-transformed measures of plasma fatty acids